Lisa K Jennings Selected Research

Lisa K Jennings Research Topics

Disease

23	Acute Coronary Syndrome 11/2023 - 02/2002
17	Thrombosis (Thrombus) 11/2023 - 03/2003
16	Hemorrhage 01/2020 - 06/2006
10	Myocardial Infarction 01/2020 - 02/2002
5	Neoplasms (Cancer) 02/2016 - 03/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2010 - 03/2007
3	Vascular Diseases (Vascular Disease) 03/2022 - 12/2003
3	Neoplasm Metastasis (Metastasis) 12/2013 - 03/2011
3	Inflammation (Inflammations) 08/2012 - 05/2006
3	Vascular System Injuries 07/2009 - 12/2003
3	Neointima 04/2009 - 08/2004
3	Ischemia 10/2006 - 05/2006
3	Atherosclerosis 09/2006 - 08/2002
2	ST Elevation Myocardial Infarction 11/2023 - 08/2004
2	Diabetes Mellitus 11/2019 - 05/2006
2	Non-ST Elevated Myocardial Infarction 01/2018 - 10/2010
2	Fibrosarcoma 12/2013 - 01/2013
2	Hematoma 08/2012 - 05/2012
2	Unstable Angina 10/2010 - 02/2002
2	Hyperplasia 04/2009 - 11/2005
2	Necrosis 05/2006 - 11/2005
1	Venous Thromboembolism 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Pulmonary Embolism 01/2018
1	Shock 05/2016
1	Wounds and Injuries (Trauma) 05/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2016
1	Kidney Neoplasms (Kidney Cancer) 02/2016
1	Stroke (Strokes) 12/2014
1	Hypoxia (Hypoxemia) 08/2014
1	Lymphoma (Lymphomas) 05/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2012
1	Osteoarthritis 05/2012
1	Heart Diseases (Heart Disease) 11/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010
1	Pathologic Processes 07/2009

Drug/Important Bio-Agent (IBA)

12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 07/2008
10	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 02/2002
10	Eptifibatide (Integrilin)FDA Link 02/2010 - 02/2002
9	vorapaxarIBA 01/2020 - 03/2009
9	Clopidogrel (Plavix)FDA Link 01/2018 - 05/2006
8	Thrombin FDA Link 11/2023 - 06/2006
8	TetraspaninsIBA 02/2016 - 02/2009
5	TicagrelorIBA 03/2022 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 02/2016 - 05/2006
5	Glycoproteins (Glycoprotein)IBA 10/2010 - 02/2002
4	Thrombin Receptors (Thrombin Receptor)IBA 05/2016 - 03/2014
3	Adenosine Diphosphate (ADP)IBA 08/2022 - 06/2014
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 12/2015
3	AnticoagulantsIBA 05/2015 - 07/2008
3	Platelet Membrane GlycoproteinsIBA 02/2010 - 03/2003
3	bivalirudin (Angiomax)FDA Link 07/2008 - 05/2006
2	thrombin receptor peptide SFLLRNPIBA 09/2022 - 08/2022
2	CollagenIBA 08/2022 - 11/2005
2	Prasugrel Hydrochloride FDA Link 01/2020 - 10/2010
2	fibrin fragment D (D-dimer)IBA 01/2018 - 05/2016
2	Proteins (Proteins, Gene)FDA Link 08/2014 - 03/2011
2	Matrix Metalloproteinases (MMPs)IBA 12/2013 - 01/2013
2	Biocompatible Materials (Biomaterials)IBA 08/2012 - 05/2012
2	AlginatesIBA 08/2012 - 05/2012
2	CD40 Ligand (CD40L)IBA 01/2010 - 02/2009
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2006 - 06/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2006 - 11/2004
2	AntithrombinsIBA 06/2006 - 05/2006
2	Peroxidase (Myeloperoxidase)IBA 11/2004 - 12/2003
2	Abciximab (ReoPro)FDA Link 10/2004 - 02/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2004 - 12/2003
1	selatogrelIBA 11/2023
1	Cyclooxygenase 1IBA 09/2022
1	Thromboplastin (Tissue Factor)IBA 09/2022
1	Arachidonic Acid (Vitamin F)IBA 08/2022
1	Diphosphates (Pyrophosphates)IBA 08/2022
1	RivaroxabanIBA 01/2018
1	Factor Xa (Coagulation Factor Xa)IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	protease-activated receptor 4IBA 01/2018
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2018
1	betrixabanIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2016
1	Cadherins (E-Cadherin)IBA 02/2016
1	tyrosine-4-azophenyltrimethylammonium chloride (TAPT)IBA 12/2015
1	PAR-1 ReceptorIBA 12/2014
1	benzimidazoleIBA 08/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	Proton Pump InhibitorsIBA 11/2010
1	ThienopyridinesIBA 10/2010
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 02/2010
1	IceIBA 02/2010
1	P-SelectinIBA 01/2010
1	Phosphotransferases (Kinase)IBA 02/2009

Therapy/Procedure

14	Therapeutics 11/2023 - 02/2002
9	Percutaneous Coronary Intervention 02/2010 - 02/2002
2	Injections 11/2023 - 08/2004
2	Stents 09/2010 - 05/2006
1	Dual Anti-Platelet Therapy 12/2015
1	Secondary Prevention 05/2015
1	Renal Dialysis (Hemodialysis) 07/2012
1	Intravenous Administration 02/2010
1	Ligation 04/2009